[artículo] 
inThe Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.1 (Enero - Febrero) . - pp. 37-44

Título :	Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia : Additional Results From the KINECT 3 Study
Tipo de documento:	texto impreso
Autores:	Christoph U. Correll, Autor ; Andrew J. Cutler, Autor ; John M. Kane, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 37-44
Idioma :	Inglés (eng)
Palabras clave:	Valbenazina, Discinesia tardía - tratamiento
Resumen:	In the KINECT 3 (NCT02274558; October 2014 to September 2015) study, valbenazine efficacy in tardive dyskinesia (TD) was demonstrated based on mean changes from baseline in the Abnormal Involuntary Movement Scale (AIMS) total score (sum of items 1–7).
Link:	./index.php?lvl=notice_display&id=20476

[artículo] Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia : Additional Results From the KINECT 3 Study [texto impreso] / Christoph U. Correll, Autor ; Andrew J. Cutler, Autor ; John M. Kane, Autor . - 2019 . - pp. 37-44.
Idioma : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.1 (Enero - Febrero) . - pp. 37-44

Palabras clave:	Valbenazina, Discinesia tardía - tratamiento
Resumen:	In the KINECT 3 (NCT02274558; October 2014 to September 2015) study, valbenazine efficacy in tardive dyskinesia (TD) was demonstrated based on mean changes from baseline in the Abnormal Involuntary Movement Scale (AIMS) total score (sum of items 1–7).
Link:	./index.php?lvl=notice_display&id=20476